期刊文献+

RKIP在胆囊癌中的表达及临床意义 被引量:1

Expression of RKIP and its clinical significance in gallbladder carcinoma
下载PDF
导出
摘要 目的:探讨胆囊癌中Raf激酶抑制蛋白(RKIP)的表达状况及其与胆囊癌临床病理指标和预后的可能关系.方法:2006-01/2009-06苏州大学附属第二医院胆囊癌患者50例,外科手术切除术后病理证实的存档组织蜡块.所有病例术前未进行放化疗,有完整的临床病理资料.采用免疫组织化学ElivisionPlus法,对50例原发性胆囊癌与38例慢性胆囊炎组织中RKIP表达进行检测.结果:在胆囊癌组织中表达的阳性率明显高于慢性胆囊炎组织,差异有统计学意义(74.0%vs0.8%,P<0.01).RKIP表达水平与胆囊癌患者年龄、性别、组织学类型及是否伴有结石等因素均无明显关系(P>0.05),但RKIP高表达与胆囊癌的低分级(31.8%vs92.3%,P<0.05)、淋巴结或远处转移(75.0%vs100.0%,P<0.05)以及术后生存时间减少(50.0%vs93.8%,P<0.05)有明显关系.结论:RKIP在胆囊癌中高表达可能提示其在胆囊癌的发生、发展中起重要作用. AIM: To investigate the expression of Raf kinase inhibitory protein (RKIP) in gallbladder carcinoma and to explore its possible relationship with clinicopathological parameters and prognosis of gallbladder carcinoma. METHODS: RKIP expression was examined by streptavidin peroxidase immunohistochemical method on paraffin-embedded tissue specimens from 50 patients with gallbladder cancer and 38 with chronic cholecystitis who underwent surgical treatment between January 2006 and June 2009 in Suzhou University. None of these patients received preoperative treatment, and detailed clinicopathological information was provided. RESULTS: The positive expression rate of RKIP in gallbladder carcinoma was significantly higher than in chronic cholecystitis, with statistically significant difference (74.0% vs 0.8%, P 〈 0.01). In gallbladder carcinoma, the expression of RKIP had no correlation with age, gender, histologic type and gallbladder stone (P 〉 0.05), but over- expression of RKIP correlated significantly with lower histological grading (31.8% vs 92.3%, P 〈 0.05), lymph node or distant metastasis (75.0% vs 100.0%, P 〈 0.05), and shorter survival after operation (50.0% vs 93.8%, P 〈 0.05). CONCLUSION: RKIP is overexpressed in de- velopment of gallbladder carcinoma. RKIP may play an important role in tumor progression of human gallbladder carcinoma.
出处 《世界华人消化杂志》 CAS 北大核心 2009年第24期2518-2521,共4页 World Chinese Journal of Digestology
关键词 胆囊肿瘤 RAF激酶抑制蛋白 免疫组织化学法 Gallbladder carcinoma Raf kinase in- hibitory protein Immunohistochemistry
  • 相关文献

参考文献13

  • 1Yeung K, Seitz T, Li S, Janosch P, McFerran B, Kaiser C, Fee F, Katsanakis KD, Rose DW, Mischak H, Sedivy JM, Kolch W. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 1999; 401:173-177.
  • 2Fu Z, Smith PC, Zhang L, Rubin MA, Dunn RL, Yao Z, Keller ET. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 2003; 95:878-889.
  • 3Hao XP, Willis JE, Pretlow TG, Rao JS, MacLennan GT, Talbot IC, Pretlow TP. Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions. Cancer Res 2000; 60:18-21.
  • 4Kumar S, Masood N, Shaikh AJ, Valimuhammad AT, Haider G, Lal A, Niamatullah N. Clinical presentation and outcomes of patients with biliary malignancies: the Aga Khan University experience. Asian Pac J Cancer Prev 2009; 10:463-466.
  • 5Hagan S, A1-Mulla F, Mallon E, Oien K, Ferrier R, Gusterson B, Garcia JJ, Kolch W. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res 2005; 11: 7392-7397.
  • 6Lee HC, Tian B, Sedivy JM, Wands JR, Kim M. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology 2006; 131:1208-1217.
  • 7韩海勃,张志谦,赵威.RKIP蛋白在多个人肺癌细胞系中的表达下调[J].基础医学与临床,2007,27(8):849-852. 被引量:14
  • 8Houben R, Vetter-Kauczok CS, Ortmann S, Rapp UR, Broecker EB, Becker JC. Phospho-ERK staining is a poor indicator of the mutational status of BRAF and NRAS in human melanoma. J Invest Dermatol 2008;128:2003-2012.
  • 9Zeng L, Imamoto A, Rosner MR. Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target. Expert Opin Ther Targets 2008; 12:1275-1287.
  • 10Dangi-Garimella S, Yun J, Eves EM, Newman M, Erkeland SJ, Hammond SM, Minn AJ, Rosner MR. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J 2009; 28:347-358.

二级参考文献8

  • 1Eves E, Shapiro P, Naik K, et al. Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint [J]. Mol Cell, 2006, 23 (4): 561-574.
  • 2Yeung K, Rose D, DhillonA S, et al. Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation [J]. Mol Cell Biol, 2001,21 (21) : 7207 - 7217.
  • 3Lorenz K, Lohse M, Quitterer U. Protein kinase C switches the Raf kinase inhibitor from Rafol to GRK-2 [J]. Nature, 2003, 426 (6966) : 574 - 579.
  • 4Lee HC, Tian B, Sedivy JM, et al. Loss of raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells [J]. Gastroenterology, 2006, 131 (4) :1208 - 1217.
  • 5Fu Z, Kitagawa Y, Shen R, et al. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer [J]. Prostate, 2006, 66 (3) : 248-256.
  • 6Hagan S, Al-Mulla F, Mallon E, et al. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis [J]. Clin Cancer Res,2005, (20) :7392 - 7397.
  • 7Schuierer MM, Bataille F, Weiss TS, et al. Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma [J]. Oncol Rep, 2006,16 (3) :451 - 456.
  • 8Park S, Yeung ML, Beach S, et al. RKIP downregulates B-Raf kinase activity in melanoma cancer cells [J]. Oncogene, 2005,24 (21) : 3535 - 3540.

共引文献13

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部